Erne P, Chiesi M, Longoni S, Fulbright J, Hermsmeyer K
Cardiovascular Research Laboratory, Chiles Research Institute, Providence Medical Center, Portland, Oregon 97213.
J Clin Invest. 1989 Aug;84(2):493-8. doi: 10.1172/JCI114191.
Effects of peripheral benzodiazepine receptor modulating drugs, Ro 5-4864 and PK 11195, on tension induced by K+ and the calcium agonist SDZ 202 791 (S isomer), were studied in rat caudal arteries. A significant reduction of tonic phase tension occurred with 30 nM PK 11195 or 3 microM Ro 5-4864, but decreases of the initial (first 3 min), phasic contraction were detected only at the highest concentrations of Ro 5-4864 and PK 11195. Protoporphyrin IX, the putative endogenous ligand of the peripheral benzodiazepine receptor, (at 10-100 nM) markedly increased the effectiveness of Ro 5-4864 and PK 11195 in reducing phasic contraction. Intracellular calcium localization and distribution in fura-2 loaded single vascular cells were quantitated using a high sensitivity, two-stage microchannel plate, photon-counting (PMI-VIM) camera. Peripheral benzodiazepines reduced intracellular calcium release from centrally located calcium pools, and this decrease of calcium release was potentiated by protoporphyrin IX. The decrease in intracellular calcium activity, which was more pronounced in the central regions where sarcoplasmic reticular elements are numerous, was probably the major mechanism of these vasodilator properties. Measurements of soluble guanylate cyclase activity also supported the intracellular Ca2+ release mechanism. Under conditions where protoporphyrin IX did not significantly stimulate guanylate cyclase, Ro 5-4864 alone or more effectively in combination with protoporphyrin IX stimulated cGMP production and caused relaxation. Guanylate cyclase forms a possible target for these benzodiazepine modulators, a hypothesis that merits further investigation.
在大鼠尾动脉中研究了外周苯二氮䓬受体调节药物Ro 5-4864和PK 11195对钾离子(K+)和钙激动剂SDZ 202 791(S异构体)诱导的张力的影响。30 nM的PK 11195或3 μM的Ro 5-4864可使强直相张力显著降低,但仅在Ro 5-4864和PK 11195的最高浓度下才检测到初始(最初3分钟)相收缩的降低。外周苯二氮䓬受体的假定内源性配体原卟啉IX(10 - 100 nM)显著增强了Ro 5-4864和PK 11195在减少相收缩方面的有效性。使用高灵敏度的两级微通道板光子计数(PMI-VIM)相机对负载fura-2的单个血管细胞内钙的定位和分布进行了定量。外周苯二氮䓬类药物减少了位于中央的钙库的细胞内钙释放,并且原卟啉IX增强了这种钙释放的减少。细胞内钙活性的降低在肌浆网元件众多的中央区域更为明显,这可能是这些血管舒张特性的主要机制。可溶性鸟苷酸环化酶活性的测量也支持细胞内Ca2+释放机制。在原卟啉IX未显著刺激鸟苷酸环化酶的条件下,单独的Ro 5-4864或与原卟啉IX联合使用时更有效地刺激了cGMP的产生并引起舒张。鸟苷酸环化酶可能是这些苯二氮䓬调节剂的一个靶点,这一假设值得进一步研究。